# Strategies for Hepatitis C Testing and Treatment in Aboriginal Communities That Lead to Elimination

> **NCT03776760** · — · UNKNOWN · sponsor: **Kirby Institute** · enrollment: 600 (estimated)

## Conditions studied

- Hepatitis C
- Hepatitis
- Liver Diseases
- Hepatitis, Viral, Human
- RNA Virus Infections
- Digestive System Diseases

## Interventions

- **DEVICE:** Fingerstick GeneXpert HCV RNA quantitative assay
- **DRUG:** sofosbuvir/velpatesvir
- **DRUG:** glecaprevir/pibrentasvir

## Key facts

- **NCT ID:** NCT03776760
- **Lead sponsor:** Kirby Institute
- **Sponsor class:** OTHER_GOV
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-05-28
- **Primary completion:** 2022-08
- **Final completion:** 2022-08
- **Target enrollment:** 600 (ESTIMATED)
- **Last updated:** 2022-04-14

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03776760

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03776760, "Strategies for Hepatitis C Testing and Treatment in Aboriginal Communities That Lead to Elimination". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT03776760. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*